⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3995513 | 0.69 | — | — | |
| SCHEMBL11844328 | 0.67 | GPR84 (0.50) | — | |
| SCHEMBL18836780 | 0.67 | GPR84 (0.52) | — | |
| SCHEMBL189997 | 0.67 | — | — | |
| SCHEMBL13918178 | 0.67 | — | — | |
| SCHEMBL3362001 | 0.67 | — | — | |
| SCHEMBL60308 | 0.67 | — | — | |
| SCHEMBL325682 | 0.67 | — | — | |
| SCHEMBL1896344 | 0.67 | — | — | |
| SCHEMBL1774205 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102676595-A | Method for producing reduced coenzyme Q10 by fermentation of recombinant strains | SUZHOU HYGIA BIOLOG TECHNOLOGY CO LTD | 2012-09-19 | — | — | CN | claimed |
| CN-102676595-A | Method for producing reduced coenzyme Q10 by fermentation of recombinant strains | SUZHOU HYGIA BIOLOG TECHNOLOGY CO LTD | 2012-09-19 | — | — | CN | disclosed |
| US-6017923-A | Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents | HOECHST MARION ROUSSEL, INC. (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0705264-B1 | CARBO-ACYCLIC NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AND ANTINEOPLASTIC AGENTS | MERRELL PHARMA INC (US) | 1999-04-07 | — | — | EP | disclosed |
| CN-1204648-A | Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents | MERRELL PHARMA INC (US) | 1999-01-13 | — | — | CN | disclosed |
| CN-1040759-C | Carbo-acyclic nucleoside derivatives as antiviral and antitumor agents | MERRELL DOW PHARMA (US) | 1998-11-18 | — | — | CN | disclosed |
| CN-1125947-A | Carbo-acyclic nucleoside derivatives as antiviral and antitumor agents | MERRELL DOW PHARMA (US) | 1996-07-03 | — | — | CN | disclosed |
| EP-0705264-A1 | CARBO-ACYCLIC NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AND ANTINEOPLASTIC AGENTS | MERRELL PHARMACEUTICALS INC. (US) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995000515-A1 | CARBO-ACYCLIC NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AND ANTINEOPLASTIC AGENTS | MERRELL PHARMACEUTICALS INC. (US) | 1995-01-05 | — | — | WO | disclosed |